Quick Takeaways
- Royalty Pharma plc reports institutional holdings through Form 13F filings.
- Latest reported quarter is not available.
- Latest reported holdings value is not available.
- Info
- Portfolio
- Insider Ownership
- Insider Trading
- Financials
- Holders
13F Filings History of Royalty Pharma plc
- Latest 13F report
- Q4 2025 - 01 Apr 2026
- Location
- New York, NY
- Summary
- This page shows a list of all the recent 13F filings made by Royalty Pharma plc. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Royalty Pharma Sub-Manager, LLC is reporting for Royalty Pharma plc.
Follow Filing Activity
Follow Royalty Pharma plc and return when a new 13F portfolio filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- No recent 13F filing is available yet for this investor.
- This page updates when SEC Form 13F disclosures are published.
Why This Matters
- This gives a plain-language read of holdings direction before you open full quarter tables.
- Use the filing links below to verify the exact SEC source document.
Official SEC Source
Backed by Form 13F
Portfolio holdings and changes are grounded in SEC Form 13F filings.
See Original FilingRoyalty Pharma Sub-Manager, LLC is reporting for Royalty Pharma plc:
| Name | Holdings Value | Location | File Number |
|---|---|---|---|
| Royalty Pharma Sub-Manager, LLC | $125,447,273 | New York, NY | 028-26787 |